Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 26, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

873

Cholangiocarcinoma.

Michela Squadroni1, Luca Tondulli2, Gemma Gatta3

  • 1Medical Oncology Unit, Humanitas Gavazzeni, Bergamo, Italy.

Critical Reviews in Oncology/Hematology
|July 12, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International variation in child healthcare practices and implications for childhood cancer diagnosis: a scoping review and cross-country clinician survey.

European journal of pediatrics·2026
Same author

Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

Cancer·2026
Same author

Neuroblastoma by Stage at Diagnosis and Other Prognostic Factors: The Results of the BENCHISTA Italian Project-A Population-Based Study.

Cancers·2026
Same author

Stage at Diagnosis and International Survival Variation in Childhood Tumors in the BENCHISTA Study.

JAMA network open·2026
Same author

Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014.

Journal of cancer policy·2026
Same author

Improving the Connection Between Population-Based and National Clinical Pediatric Cancer Registries-A Pilot Study on Neuroblastoma: The Italian BENCHISTA-Ita Project.

Cancers·2025
Same journal

Estrobolome and the Endocrine-Microbiome Axis in Breast and Endometrial Carcinogenesis.

Critical reviews in oncology/hematology·2026
Same journal

Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant immunotherapy in melanoma: From pathologic response to response-adapted management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
See all related articles

Biliary tract cancers, including cholangiocarcinoma and gallbladder cancer, are rare and primarily affect older men. Current treatments involve surgery, radiation, and chemotherapy, with gemcitabine and cisplatin as standard for advanced disease.

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Biliary tract cancers (BTC) represent less than 1% of all malignancies.
  • These cancers predominantly affect an elderly male population.
  • Key subtypes include intrahepatic, hilar, and distal cholangiocarcinoma, along with gallbladder cancer, each with distinct characteristics.

Purpose of the Study:

  • To provide an overview of biliary tract cancers.
  • To outline current therapeutic strategies.
  • To highlight future directions in treatment.

Main Methods:

  • Review of current medical literature and treatment guidelines for BTC.
  • Analysis of standard chemotherapy regimens and emerging therapeutic targets.
  • Emphasis on the role of surgery, radiotherapy, and supportive care.
Keywords:
Biliary tractcancerdiagnosisincidencemultidisciplinary treatment

More Related Videos

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

880
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.4K

Related Experiment Videos

Last Updated: Feb 26, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

873
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

880
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.4K

Main Results:

  • Surgery is the primary treatment when feasible.
  • Gemcitabine and cisplatin combination chemotherapy is the standard for advanced/metastatic BTC.
  • Fluoropyrimidines are typically used as second-line therapy.
  • No biologic drugs have shown clear efficacy to date.

Conclusions:

  • While current treatments are limited, molecular characterization offers potential for novel experimental therapies.
  • Comprehensive patient management requires robust supportive and early palliative care.